Paper Details

  1. Home
  2. Paper Details

Chemotherapy for hormone-refractory prostate cancer.

Author: ColesBernadette, HarrisonCraig, MasonMalcolm D, ShelleyMike, StaffurthJohn, WiltTimothy J

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Prostate cancer mainly affects older men and is becoming more common. Hormone therapy is the usual first treatment for advanced, widespread prostate cancer, and it works well for many men. However, many eventually develop resistance and the outlook becomes poor, especially if the cancer spreads to the bones, causing severe pain. While chemotherapy has had limited success, newer treatments show promise, highlighting the need for further research.
Paper Details　
Original Abstract of the Article :
Prostate cancer mainly affects elderly men, and its incidence has steadily increased over the last decade. The management of this disease is replete with controversy. In men with advanced, metastatic prostate cancer, hormone therapy is almost universally accepted as the initial treatment of choice a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD005247.pub2

データ提供：米国国立医学図書館（NLM）

Chemotherapy for Hormone-Refractory Prostate Cancer: A Camel's Trek Through a Challenging Landscape

Prostate cancer, a disease primarily affecting older men, can be a challenging journey to navigate. While hormone therapy is often the first line of defense, many patients eventually develop resistance to this treatment. This study explores the role of chemotherapy in managing hormone-refractory prostate cancer (HRPC), evaluating the effectiveness of various chemotherapy regimens in this challenging context.

A New Oasis: Exploring Chemotherapy for Hormone-Refractory Prostate Cancer

This study, like a camel caravan seeking a new oasis, delves into the potential of chemotherapy as a treatment option for HRPC. The authors acknowledge the historical challenges of using chemotherapy for HRPC but highlight the encouraging results emerging from trials with newer agents. The research suggests that chemotherapy may offer a valuable tool for managing HRPC and improving patient outcomes.

Health Implications and Lifestyle Applications

Prostate cancer is a serious health concern, and HRPC presents a significant challenge. This study underscores the importance of exploring all available treatment options and discussing potential risks and benefits with healthcare professionals. It's crucial to maintain a healthy lifestyle, including a balanced diet and regular exercise, to support overall health and well-being.

Dr.Camel's Conclusion

The desert of HRPC can be a daunting journey, but this study offers a glimmer of hope in the form of new chemotherapy approaches. The research provides a roadmap for future clinical trials and highlights the importance of personalized treatment plans to address the unique needs of each patient. By working closely with healthcare professionals, individuals can navigate this challenging terrain with greater strength and resilience.

Date :
  1. Date Completed 2007-01-19
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

17054249

DOI: Digital Object Identifier

10.1002/14651858.CD005247.pub2

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.